SCHEMBL6096166

SCHEMBL6096166

COc1ccc(C(=O)Oc2cc(O)c3c(=O)cc(-c4ccc(OC)c(OC)c4)oc3c2)cc1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1B1 Q16678 5/20 0.72
▸ CYP1A1 P04798 4/20 0.62
▸ CYP1A2 P05177 4/20 0.62
▸ IP6K2 Q9UHH9 3/20 0.62
▸ MEN1 O00255 3/20 0.62
▸ KMT2A Q03164 3/20 0.62
▸ MAPT P10636 3/20 0.62
▸ ABCC1 P33527 2/20 0.62
▸ HDAC6 Q9UBN7 2/20 0.62
▸ ALDH1A1 P00352 2/20 0.62
▸ KDM1A O60341 1/20 0.62
▸ XDH P47989 1/20 0.62
▸ IPMK Q8NFU5 1/20 0.62
▸ POLB P06746 1/20 0.62
▸ KCNA5 P22460 2/20 0.59
▸ KCNH2 Q12809 2/20 0.59
▸ PLG P00747 1/20 0.58
▸ OPRD1 P41143 1/20 0.58
▸ FLT3 P36888 2/20 0.58
▸ MAOB P27338 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1421382 0.86 CYP1B1 (0.86) CYP1B1CYP1A1CYP1A2IP6K2MEN1
SCHEMBL29845342 0.86 CYP1B1 (0.86) CYP1B1CYP1A1CYP1A2IP6K2MEN1
SCHEMBL27907057 0.85 CYP1B1 (0.84) CYP1B1CYP1A1CYP1A2IP6K2MEN1
Methane SCHEMBL27890494 0.85 CYP1B1 (0.84) CYP1B1CYP1A1CYP1A2IP6K2MEN1
SCHEMBL2483636 0.84 CYP1B1 (1.00) CYP1B1CYP1A1CYP1A2IP6K2MEN1
SCHEMBL30365934 0.84 CYP1B1 (1.00) CYP1B1CYP1A1CYP1A2IP6K2MEN1
SCHEMBL29883103 0.84 CYP1B1 (1.00) CYP1B1CYP1A1CYP1A2IP6K2MEN1
SCHEMBL7605191 0.81 CYP1B1 (0.72) CYP1B1CYP1A1CYP1A2IP6K2MEN1
SCHEMBL14178914 0.80 CYP1B1 (0.71) CYP1B1CYP1A1CYP1A2IP6K2MEN1
Velutin SCHEMBL5804380 0.79 CYP1B1 (0.86) CYP1B1CYP1A1CYP1A2IP6K2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7009062-B2 Process for the preparation of flavone derivatives MERCK PATENT GMBH (DE) 2006-03-07 — — US disclosed
EP-1355898-B1 METHOD FOR PRODUCING FLAVONE DERIVATIVES MERCK PATENT GMBH (DE) 2005-10-12 — — EP disclosed
US-20040059100-A1 Process for the preparation of flavone derivatives EUROPEAN BRAND PARTICIPATIONS SA (LU) 2004-03-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040059100-A1 Process for the preparation of flavone derivatives HK2, MAP2K5, MAP2K4 CYP1B1 263/4885CYP1A1 242/4885CYP1A2 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback